NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3,4-dichloro-1H-isochromen-1-one
|
|
|
IUPAC Traditional name
|
3,4-dichloroisocoumarin
|
@3,4-dichloroisocoumarin
|
|
|
Synonyms
|
3,4-Dichloro-2-benzopyran-1-one
|
3,4-DCI
|
3,4-Dichloroisocoumarin
|
3,4-Dichloroisocoumarin
|
|
|
CAS Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
H Acceptors
|
1
|
H Donor
|
0
|
LogD (pH = 5.5)
|
2.8767645
|
LogD (pH = 7.4)
|
2.8767645
|
Log P
|
2.8767645
|
Molar Refractivity
|
61.0524 cm3
|
Polarizability
|
19.454998 Å3
|
Polar Surface Area
|
26.3 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
Log P
|
3.14
|
LOG S
|
-3.49
|
Solubility (Water)
|
6.97e-02 g/l
|
DETAILS
DETAILS
MP Biomedicals
DrugBank
Sigma Aldrich
MP Biomedicals -
02158836
|
Reversible inhibitor of serine proteases, including chymotrypsin, trypsin, clotting factors XIa and XIIa. Also inhibits some endopeptidase such as protease (Staph. V-8). Does not inhibit papain. |
Sigma Aldrich -
D7910
|
Application Useful in a rapid staining method for identification of macrophages; counts by this method were confirmed by the more complex morphological criteria, by phagocytosis, and by the presence of Fc receptors.1 Other Notes Effective concentration 5-100 μM. Quantity Half-life = 20 min at pH 7.5. Substrates Serine protease inhibitor. Active towards a wide range of serine proteases including granzymes. Not active toward β-lactamases. |
Sigma Aldrich -
35913
|
Other Notes Effective concentration 5-100 μM. Inhibitor of serine proteases1; Inhibition of porcine pancreatic elastase2 Quantity Half-life = 20 min at pH 7.5. Substrates Serine protease inhibitor. Active towards a wide range of serine proteases including granzymes. Not active toward β-lactamases. Biochem/physiol Actions Inhibitor of serine proteases1 and porcine pancreatic elastase2. Treatment of proteasomes leads to rapid inactivation of chymotrypsin-like activity and slower inactivation of other proteases.3 |
PATENTS
PATENTS
PubChem Patent
Google Patent